2.30
2.30 (0%)
As of Apr 17, 2025
Sonoma Pharmaceuticals, Inc. [SNOA]
Source:
Company Overview
Sonoma Pharmaceuticals, Inc is a global healthcare leader for developing and producing stabilized hypochlorous acid, or HOCl, products for a wide range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants.
| Country | United States |
| Headquarters | boulder, colorado |
| Phone Number | (800) 759-9305 |
| Industry | manufacturing |
| CEO | Amy Trombly |
| Website | www.sonomapharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $3.6 |
| Operating Profit | $-1 |
| Net Income | $-0.9 |
| Net Cash | $2.1 |
Profit Ratios
| Gross Margin | $1.3 |
| Operating Margin | -28.9 |
| Profit as % of Revenues | -136.9% |
| Profit as % of Assets | -6.5% |
| Profit as % of Stockholder Equity | -19.1% |
Management Effectiveness
| Return on Equity | -19.1% |
| Return on Assets | -6.8% |
| Turnover Ratio | 25.1% |
| EBITA | $-1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $13.7 |
| Total Liabilities | $8.8 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $2.8 |
